Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1996 1
1999 1
2001 1
2006 18
2007 96
2008 137
2009 153
2010 158
2011 189
2012 219
2013 219
2014 236
2015 267
2016 248
2017 255
2018 216
2019 246
2020 252
2021 262
2022 211
2023 213
2024 225
2025 283
2026 136

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,820 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mdr tb (7,604 results)?
Multidrug-resistant tuberculosis.
Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR Jr, Murray M, Lange C. Dheda K, et al. Nat Rev Dis Primers. 2024 Mar 24;10(1):22. doi: 10.1038/s41572-024-00504-2. Nat Rev Dis Primers. 2024. PMID: 38523140 Review.
Pre-extensively drug-resistant TB (pre-XDR-TB) refers to MDR/RR-TB that is also resistant to a fluoroquinolone, and extensively drug-resistant TB (XDR-TB) isolates are additionally resistan …
Pre-extensively drug-resistant TB (pre-XDR-TB) refers to MDR/RR-TB that is also resistant t …
4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB.
de Souza MVN, Nogueira TCM. de Souza MVN, et al. Curr Top Med Chem. 2019;19(8):567-578. doi: 10.2174/1568026619666190305130809. Curr Top Med Chem. 2019. PMID: 30834835 Review.
Nowadays, tuberculosis (TB) is an important global public health problem, being responsible for millions of TB-related deaths worldwide. Due to the increased number of cases and resistance of Mycobacterium tuberculosis to all drugs used for the treatme …
Nowadays, tuberculosis (TB) is an important global public health problem, being responsible for millions of TB-related …
Drug resistant TB - latest developments in epidemiology, diagnostics and management.
Tiberi S, Utjesanovic N, Galvin J, Centis R, D'Ambrosio L, van den Boom M, Zumla A, Migliori GB. Tiberi S, et al. Int J Infect Dis. 2022 Nov;124 Suppl 1:S20-S25. doi: 10.1016/j.ijid.2022.03.026. Epub 2022 Mar 25. Int J Infect Dis. 2022. PMID: 35342000 Free article. Review.
AIM: The aim of this review is to inform the reader on the latest developments in epidemiology, diagnostics and management. EPIDEMIOLOGY: Drug-resistant Tuberculosis (DR-TB) continues to be a current global health threat, and is defined by higher morbi …
AIM: The aim of this review is to inform the reader on the latest developments in epidemiology, diagnostics and management. EPIDEMIOLOGY: …
Drug resistant Tuberculosis: A review.
Khawbung JL, Nath D, Chakraborty S. Khawbung JL, et al. Comp Immunol Microbiol Infect Dis. 2021 Feb;74:101574. doi: 10.1016/j.cimid.2020.101574. Epub 2020 Nov 16. Comp Immunol Microbiol Infect Dis. 2021. PMID: 33249329 Review.
The pathogenic organism Mycobacterium tuberculosis continuously evolved to resist the antagonist drugs. This has led to the outbreak of resistant strain that gave rise to "Multi Drug Resistant-Tuberculosis" and "Extensively Drug Resist …
The pathogenic organism Mycobacterium tuberculosis continuously evolved to resist the antagonist drugs. This has led to the outbreak …
XDR-TB, what is it; how is it treated; and why is therapeutic failure so high?
Gillespie SH, Singh K. Gillespie SH, et al. Recent Pat Antiinfect Drug Discov. 2011 May;6(2):77-83. doi: 10.2174/157489111796064641. Recent Pat Antiinfect Drug Discov. 2011. PMID: 21595627 Review.
Drug resistance is a major hurdle in the global battle against tuberculosis (TB). In tackling this problem it is important to understand both how resistance emerges as well as the ways in which multi-drug and extensively drug-resistant TB …
Drug resistance is a major hurdle in the global battle against tuberculosis (TB). In tackling this problem it is important to …
Global burden of MDR-TB and XDR-TB: trends, inequities, and future implications for public health planning.
Tan EL, Qin Y, Yang J, Li XJ, Liu TQ, Yang GB, Li YJ, Zhang ZZ, Lu ZH, Wang JC, Zheng JX, Zhang SX. Tan EL, et al. BMC Infect Dis. 2025 Oct 2;25(1):1225. doi: 10.1186/s12879-025-11566-2. BMC Infect Dis. 2025. PMID: 41039228 Free PMC article.
BACKGROUND: Drug-resistant tuberculosis (TB) remains a major global health threat, reflecting disparities in healthcare capacity, access, and socioeconomic development. ...This study provides a comprehensive assessment of the global, regional, and nati …
BACKGROUND: Drug-resistant tuberculosis (TB) remains a major global health threat, reflecting disparities in hea …
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
Brouqui P, Quenard F, Drancourt M. Brouqui P, et al. Int J Antimicrob Agents. 2017 May;49(5):554-557. doi: 10.1016/j.ijantimicag.2017.02.008. Epub 2017 Mar 21. Int J Antimicrob Agents. 2017. PMID: 28336312 Review.
Recently, multidrug-resistant tuberculosis (MDR-TB) has become a therapeutic challenge. In addition to drug resistance, drug adverse events, intravenous delivery, cost and availability of some antibiotics in low-income countries have led to a look back to old drugs, …
Recently, multidrug-resistant tuberculosis (MDR-TB) has become a therapeutic challenge. In addition to drug resistance, drug a …
Extensively Drug-resistant Tuberculosis (XDR-TB): A daunting challenge to the current End TB Strategy and policy recommendations.
Rahman MA, Sarkar A. Rahman MA, et al. Indian J Tuberc. 2017 Jul;64(3):153-160. doi: 10.1016/j.ijtb.2017.03.006. Epub 2017 Apr 8. Indian J Tuberc. 2017. PMID: 28709481 Review.
Extensively Drug-resistant Tuberculosis (XDR-TB) has emerged as one of the most formidable challenges to the End TB Strategy that has targeted a 95% reduction in TB deaths and 90% reduction in cases by 2035. Globally, there …
Extensively Drug-resistant Tuberculosis (XDR-TB) has emerged as one of the most formidable challen …
Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
Prasad R. Prasad R. Indian J Tuberc. 2010 Oct;57(4):180-91. Indian J Tuberc. 2010. PMID: 21141336 Review.
Multi Drug Resistant Tuberculosis (MDR-TB) and Extensively Drug Resistant Tuberculosis (XDR-TB) are posing a threat to the control of tuberculosis. ...China and India carry approximately 50% of the globa …
Multi Drug Resistant Tuberculosis (MDR-TB) and Extensively Drug Resistant Tuberculosis …
Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, Lange C. Dheda K, et al. Respirology. 2018 Jan;23(1):36-45. doi: 10.1111/resp.13143. Epub 2017 Aug 29. Respirology. 2018. PMID: 28850767 Free article. Review.
The advent of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) threatens to further destabilize control in several regions of the world. Drug-resistant TB constitutes a signific …
The advent of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB …
3,820 results